🔎 Trials Near Me

Utama › Kanser Darah › California › Los Angeles

Kajian klinikal Kanser Darah di Los Angeles, CA

17 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Mengambil pesertaFasa 3
  • UCLA - Hematology/Oncology - Administrative Office ( Site 0009), Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03486873

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Mengambil pesertaFasa 3
  • Quetzal Site 7, Los Angeles
Umur 18 hingga 71 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07504458

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Mengambil pesertaFasa 2
  • UCLA Medical Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04996875

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Mengambil pesertaFasa 3
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Health - Bowyer Oncology Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Mengambil pesertaFasa 1
  • University of California, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06823167

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Mengambil pesertaFasa 1
  • Cedars-Sinai Medical Center, Los Angeles
Umur 18 hingga 85 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05887167

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Mengambil pesertaFasa 1
  • Cedars-Sinai Medical Center, Los Angeles
Umur 65 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT05849207

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Mengambil pesertaFasa 1
  • START Los Angele, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07424833

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Mengambil pesertaFasa 2
  • UCLA Department of Medicine, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • UCLA, Los Angeles
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Mengambil pesertaFasa 3
  • University of California LA, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT06401356

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Umur 19 ke atas · Semua jantina · Dikemas kini 2 Apr 2026 · NCT03207854

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Mengambil pesertaFasa 1
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UCLA - Bowyer Oncology Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT05735184

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Mengambil pesertaKajian pemerhatian
  • University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2025 · NCT05768269

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Mengambil pesertaFasa 1/2
  • Valkyrie Clinical Trials, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2025 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Mengambil pesertaFasa 1
  • Children's Hospital Los Angeles, Los Angeles
Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770

Kajian Kanser Darah di bandar lain

Kajian lain di Los Angeles

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.